相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Body Mass Index Does Not Impact Clinical Efficacy of Ustekinumab in Crohn's Disease: A Post Hoc Analysis of the IM-UNITI Trial
Emily C. L. Wong et al.
INFLAMMATORY BOWEL DISEASES (2021)
A review of endoscopic scoring systems and their importance in a treat-to-target approach in inflammatory bowel disease
Jimmy K. Limdi et al.
GASTROINTESTINAL ENDOSCOPY (2020)
Associations Between Obesity and the Effectiveness of Anti-Tumor Necrosis Factor-α Agents in Inflammatory Bowel Disease Patients: A Literature Review and Meta-analysis
Zhang-han Dai et al.
ANNALS OF PHARMACOTHERAPY (2020)
The Effect of Adiposity on Anti-Tumor Necrosis Factor-Alpha Levels and Loss of Response in Crohn's Disease Patients
Zixiang Lim et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2020)
Predicting Response to Vedolizumab in Inflammatory Bowel Disease
Joseph Meserve et al.
FRONTIERS IN MEDICINE (2020)
The Association of Abdominal Adiposity With Mortality in Patients With Stage I-III Colorectal Cancer
Justin C. Brown et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life
Robert Venning Bryant et al.
INFLAMMATORY BOWEL DISEASES (2019)
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
Ian J. Neeland et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
Nicholas A. Kennedy et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Automated Abdominal Segmentation of CT Scans for Body Composition Analysis Using Deep Learning
Alexander D. Weston et al.
RADIOLOGY (2019)
Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical Trials
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Fully automated segmentation and quantification of visceral and subcutaneous fat at abdominal CT: application to a longitudinal adult screening cohort
Scott J. Lee et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
Visceral Fat Is Associated With Mucosal Healing of Infliximab Treatment in Crohn's Disease
Weisong Shen et al.
DISEASES OF THE COLON & RECTUM (2018)
Inclusion of the Mesentery in Ileocolic Resection for Crohn's Disease is Associated With Reduced Surgical Recurrence
Calvin J. Coffey et al.
JOURNAL OF CROHNS & COLITIS (2018)
Obesity and response to anti-tumor necrosis factor-alpha agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis
Siddharth Singh et al.
PLOS ONE (2018)
Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes
Siddharth Singh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease
Kimberley W. J. Van Der Sloot et al.
INFLAMMATORY BOWEL DISEASES (2017)
Increase of Intra-abdominal Adipose Tissue in Pediatric Crohn Disease
Klara Frivolt et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)
The body composition profile is associated with response to anti-TNF therapy in Crohn's disease and may offer an alternative dosing paradigm
N. S. Ding et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years - United States, 2015
James M. Dahlhamer et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)
Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease
M. Rosario et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
L. Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Visceral fat area is associated with a high risk for early postoperative recurrence in Crohn's disease
Y. Li et al.
COLORECTAL DISEASE (2015)
Visceral Adipose Tissue in Patients with Crohnʼs Disease Correlates with Disease Activity, Inflammatory Markers, and Outcome
Carsten Büning et al.
INFLAMMATORY BOWEL DISEASES (2015)
Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study
Hashem B. El-Serag et al.
GUT (2014)
Impact of Abdominal Visceral Adipose Tissue on Disease Outcome in Pediatric Crohn's Disease
Victor Uko et al.
INFLAMMATORY BOWEL DISEASES (2014)
Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans
B. J. Klopfenstein et al.
BRITISH JOURNAL OF RADIOLOGY (2012)
Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease
Ingrid Ordas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Impact of Obesity on Drug Metabolism and Elimination in Adults and Children
Margreke J. E. Brill et al.
CLINICAL PHARMACOKINETICS (2012)
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
Natalie A. Molodecky et al.
GASTROENTEROLOGY (2012)
Assessing Response and Loss of Response to Biological Therapies in IBD
Henit Yanai et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Feasibility of Using Single-Slice MDCT to Evaluate Visceral Abdominal Fat in an Urban Pediatric Population
Netta M. Blitman et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Ratio of Visceral to Subcutaneous Fat Area Is a Biomarker of Complicated Crohn's Disease
Bara Erhayiem et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Abdominal Visceral Adipose Tissue Volume Is Associated With Increased Risk of Erosive Esophagitis in Men and Women
Su Youn Nam et al.
GASTROENTEROLOGY (2010)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
Visceral adipose tissue: relations between single-slice areas and total volume
W Shen et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2004)